SNAPC5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.090800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.567600E-01
Normal-vs-Stage2
5.022600E-01
Normal-vs-Stage3
2.030800E-01
Normal-vs-Stage4
6.817600E-01
Stage1-vs-Stage2
3.001600E-01
Stage1-vs-Stage3
5.715700E-02
Stage1-vs-Stage4
4.943800E-01
Stage2-vs-Stage3
2.251000E-01
Stage2-vs-Stage4
8.388600E-01
Stage3-vs-Stage4
1.351770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.657000E-01
Normal-vs-AfricanAmerican
5.644000E-01
Normal-vs-Asian
2.088400E-01
Caucasian-vs-AfricanAmerican
7.878400E-01
Caucasian-vs-Asian
1.289790E-02
AfricanAmerican-vs-Asian
2.771000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.896200E-01
Normal-vs-Female
5.555400E-01
Male-vs-Female
5.106400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.124000E-01
Normal-vs-Age(41-60Yrs)
6.956000E-01
Normal-vs-Age(61-80Yrs)
4.399000E-01
Normal-vs-Age(81-100Yrs)
4.173400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.145800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.567600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.598780E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.035790E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.132800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.327200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.769600E-01
Normal-vs-Daily Drinker
4.386000E-01
Normal-vs-Weekly Drinker
5.392400E-01
Normal-vs-Occasional Drinker
4.962400E-01
Normal-vs-Social Drinker
7.491800E-01
Non Drinker-vs-Daily Drinker
5.434200E-01
Non Drinker-vs-Weekly Drinker
7.576800E-01
Non Drinker-vs-Occasional Drinker
9.490400E-01
Non Drinker-vs-Social Drinker
4.865400E-01
Daily Drinker-vs-Weekly Drinker
8.589000E-01
Daily Drinker-vs-Occasional Drinker
5.608200E-01
Daily Drinker-vs-Social Drinker
3.060400E-01
Weekly Drinker-vs-Occasional Drinker
7.481800E-01
Weekly Drinker-vs-Social Drinker
4.625800E-01
Occasional Drinker-vs-Social Drinker
5.507600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.570400E-01
Normal-vs-Grade 2
8.299000E-01
Normal-vs-Grade 3
8.068000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.576600E-01
Grade 1-vs-Grade 3
4.323400E-01
Grade 1-vs-Grade 4
8.570400E-01
Grade 2-vs-Grade 3
6.372200E-01
Grade 2-vs-Grade 4
8.299000E-01
Grade 3-vs-Grade 4
8.068000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.152600E-01
Normal-vs-NonDiabetic
5.647600E-01
Diabetic-vs-NonDiabetic
4.550600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.746400E-01
Normal-vs-NoPancreatitis
5.031400E-01
Pancreatitis-vs-NoPancreatitis
3.977900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.115600E-01
Normal-vs-N1
5.606600E-01
N0-vs-N1
5.892200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.393200E-01
Normal-vs-TP53-NonMutant
5.440600E-01
TP53-Mutant-vs-TP53-NonMutant
3.195800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
